260 related articles for article (PubMed ID: 2242614)
1. The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.
Yoo YK; Gavaler JB; Chen K; Whiteside TL; van Thiel DH
Clin Exp Immunol; 1990 Nov; 82(2):338-43. PubMed ID: 2242614
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon. Its effect upon lymphocyte subpopulations and HLA-DR expression within the liver.
Yoo YK; Gavaler JS; Chen KN; Dindzans V; Brouillette DE; Whiteside TL; Van Thiel DH
Dig Dis Sci; 1989 Nov; 34(11):1758-64. PubMed ID: 2531067
[TBL] [Abstract][Full Text] [Related]
3. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
Senaldi G; Portmann B; Mowat AP; Mieli-Vergani G; Vergani D
Arch Dis Child; 1992 Dec; 67(12):1447-53. PubMed ID: 1489223
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical investigation of hepatitis B virus associated antigens, HLA antigens and lymphocyte subsets in type B chronic hepatitis.
Aoyama K; Kojima T; Inoue K; Sasaki H
Gastroenterol Jpn; 1990 Feb; 25(1):41-53. PubMed ID: 2407598
[TBL] [Abstract][Full Text] [Related]
6. Hepatic HLA antigen display in chronic hepatitis B virus infection. Relation to hepatic expression of HBV genome/gene products and liver histology.
Lau JY; Bird GL; Naoumov NV; Williams R
Dig Dis Sci; 1993 May; 38(5):888-95. PubMed ID: 7683263
[TBL] [Abstract][Full Text] [Related]
7. alpha-Interferon therapy in patients with chronic active hepatitis B: immunological profile.
Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagra F; Vacolas J; Goulis G; Vrettou H
J Investig Allergol Clin Immunol; 1991 Oct; 1(5):330-4. PubMed ID: 1669591
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
[TBL] [Abstract][Full Text] [Related]
9. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue.
Jilbert AR; Burrell CJ; Gowans EJ; Hertzog PJ; Linnane AW; Marmion BP
Hepatology; 1986; 6(5):957-61. PubMed ID: 3530948
[TBL] [Abstract][Full Text] [Related]
10. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis.
Colucci G; Colombo M; Del Ninno E; Paronetto F
Gastroenterology; 1983 Nov; 85(5):1138-45. PubMed ID: 6225691
[TBL] [Abstract][Full Text] [Related]
11. [Relation of HLA-I and HLA-DR to HBV-infected liver].
Na J
Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):271-3. PubMed ID: 1813161
[TBL] [Abstract][Full Text] [Related]
12. Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.
Si L; Whiteside TL; Van Thiel DH; Rabin BS
Lab Invest; 1984 Mar; 50(3):341-7. PubMed ID: 6366363
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C.
Hayata T; Nakano Y; Yoshizawa K; Sodeyama T; Kiyosawa K
Hepatology; 1991 Jun; 13(6):1022-8. PubMed ID: 1711000
[TBL] [Abstract][Full Text] [Related]
14. Studies of lymphocyte subpopulations in the liver tissue and blood of patients with chronic active hepatitis (CAH).
Si LS; Whiteside TL; Schade RR; Van Thiel DH
J Clin Immunol; 1983 Oct; 3(4):408-19. PubMed ID: 6606644
[TBL] [Abstract][Full Text] [Related]
15. [Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis].
Kalyuzhin OV; Ponezheva ZB; Semenova IV; Khokhlova ON; Serebrovskaya LV; Guseva TS; Parshina OV; Maleev VV
Ter Arkh; 2017; 89(11):14-20. PubMed ID: 29260741
[TBL] [Abstract][Full Text] [Related]
16. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
Chen Y; Wei H; Sun R; Tian Z
Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
18. Effect of low dosage of interferon on natural killer activity in patients with HBsAg-positive chronic active hepatitis.
Matsumura N; Yoshikawa T; Kondo M; Imanishi J; Kishida T
Digestion; 1984; 30(4):195-9. PubMed ID: 6510570
[TBL] [Abstract][Full Text] [Related]
19. Expression of ras and c-myc oncoproteins and hepatitis B surface antigen in human liver disease.
Tiniakos D; Spandidos DA; Yiagnisis M; Tiniakos G
Hepatogastroenterology; 1993 Feb; 40(1):37-40. PubMed ID: 8462926
[TBL] [Abstract][Full Text] [Related]
20. [The interrelation of the expression of HLA class I and II proteins and of the costimulatory proteins CD11a/CD18 and CD16 with the lytic activity of resting and activated natural killer lymphocytes].
Musatov MI; Petrova ED; Konenkov VI
Tsitologiia; 1997; 39(7):617-28. PubMed ID: 9490502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
